Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Xuanbi Antong Fang (宣痹安痛方) is a traditional Chinese medicine (TCM) formula developed for the treatment of pain conditions associated with "Bi syndrome," particularly those involving damp-heat obstruction in the meridians and joints. The formula is based on principles of clearing heat, promoting blood circulation, resolving phlegm, and relieving pain. Preclinical research indicates that it may improve cardiac function after myocardial infarction in animal models by modulating inflammatory cytokines such as TNF-α, IL-6, IL-10, and Caspase-3[4]. The specific herbal composition typically includes ingredients known for their effects on clearing heat, dispelling dampness, activating blood flow, and alleviating pain; however, exact ingredient lists may vary depending on clinical application or modification.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Xuanbi Antong Fang.